In lung cancer, tumors with low IRS-1 and high IRS-2 expression were associated with poor outcomes in adenocarcinoma and squamous cell carcinoma, indicating a potential role for IRS-2 in the aggressive behavior of non-small cell lung cancer [25]. This evidence concerns the gene IRS2 and adenocarcinoma.